<DOC>
	<DOCNO>NCT00049881</DOCNO>
	<brief_summary>To conduct genetic study metabolic syndrome characterize low level high density lipoprotein cholesterol ( HDL-C ) , hypertriglyceridemia , obesity .</brief_summary>
	<brief_title>Genetic Determinants : Low HDL , High Triglycerides , Obesity</brief_title>
	<detailed_description>BACKGROUND : Over past 10 year , extensive study conduct Turkey determine risk factor heart disease . Studies involve approximately 10,000 Turkish men woman six different region Turkey establish population unique several way . The Turks low plasma level high density lipoprotein cholesterol ( HDL-C ) almost population world ( 75 percent men 50 percent woman HDL-C level &lt; 40 mg/dl ) . The mean HDL-C level 10-15 mg/dl low Western European American population . In addition , Turks , especially Turkish woman , tendency toward obesity [ 38.8 percent woman body mass index ( BMI ) &gt; 30 kg/M2 ] , men woman tendency toward hypertriglyceridemia . The low HDL-C , however , independent obesity hypertriglyceridemia . Samples well-characterized population provide unique opportunity explore genetic determinant associate high prevalence low HDL-C , hypertriglyceridemia , obesity ( characteristic metabolic syndrome ) . The study response Request Applications entitle `` NHLBI Innovative Research Grant Program '' release July , 2001 . The purpose initiative support new approach heart , lung , blood disease sleep disorder use exist data set exist biological specimen collection whether obtain National Heart , Lung , Blood Institute support . DESIGN NARRATIVE : The study analyze DNA frozen blood sample investigate new candidate gene target provide insight abnormality characterize population Turks . The sample extensive biodata available 10,000 participant . In Specific Aim 1 , investigator identify polymorphisms acyl CoA : diacylglycerol acyltranferase ( DGAT ) - I -2 ATP-binding cassette A I ( ABCA I ) gene associate difference BMI , HDL-C , triglyceride concentration , parameter blood pressure . These study focus significantly promoter cod sequence polymorphism DGAT-I -2 ABCAL In Specific Aim 2 , investigator determine whether polymorphisms functional significance use luciferase reporter system determine expression polymorphic form DGAT ABCAI , cholesterol efflux measurement determine functional significance ABCAI cod sequence polymorphic site , triglyceride synthesis assay determine functional significance DGAT-I -2 polymorphic site . The polymorphic site association study perform DNA sample three subgroup Turks : ( ) individual likely metabolic syndrome , ( b ) individual isolate low HDL-C ( normal triglyceride ) , ( c ) normolipidemic unaffected control . The study completion date list record obtain `` End Date '' enter Protocol Registration Results System ( PRS ) record .</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Hypertriglyceridemia</mesh_term>
	<criteria>No eligibility criterion</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>January 2005</verification_date>
</DOC>